Author Archives: Joseph Thornton MD

Oren Gottfried, MD ⁦‪@OGdukeneurosurg‬⁩ ECG pic.twitter.com/dj2C5hbChe 11/19/24, 8:51 AM Joseph Thornton

JAMA Psychiatry ⁦‪@JAMAPsych‬⁩ GLP-1 agonists semaglutide and liraglutide may be effective in the treatment of alcohol use disorder. ja.ma/3O4GAsr pic.twitter.com/uTyDNT7Mal 11/15/24, 12:00 PM Joseph Thornton

https://www.mdpi.com/2076-3425/14/11/1113 Joseph Thornton

JAMA Psychiatry ⁦‪@JAMAPsych‬⁩ Viewpoint discusses clinical trial results of GLP-1 receptor agonists for treating the weight gain and cardiovascular disease risk of psychiatric medications. ja.ma/4hzfSFF pic.twitter.com/YqeZH1RZN0 11/5/24, 5:00 AM Joseph Thornton

JAMA Neurology ⁦‪@JAMANeuro‬⁩ Editorial: Alzheimer Disease—What’s in a Name? #CTAD24 ja.ma/3YIyLyu pic.twitter.com/0RnxqK6KAP 11/1/24, 4:10 AM Joseph Thornton

https://www.newsweek.com/alzheimers-common-drug-dementia-brain-health-1978096 Joseph Thornton

JAMA Psychiatry ⁦‪@JAMAPsych‬⁩ This study provides the first empirical evidence suggesting that experiencing grateful affect is associated with increased longevity among older adults. ja.ma/3YEiElq pic.twitter.com/9VVmtSRVnK 10/29/24, 6:00 AM Joseph Thornton

Chris Aiken, MD ⁦‪@chrisaikenmd‬⁩ Ultra processed foods were associated with a 30% increase in #depression in large 8 year study: pubmed.ncbi.nlm.nih.gov/39426518 We’ve invented chemicals that treat depression, and others that cause it. Here are foods that improve mood: chrisaikenmd.com/antidepressant… #nutrition #mentalhealth pic.twitter.com/4fDCUQrjZb 10/29/24, 8:35 AM Joseph Thornton

Michael Okun ⁦‪@MichaelOkun‬⁩ Do you know how GLP-1 drugs were discovered? Everyone is talking about the potential for GLP-1 drugs in Parkinson’s and neurodegeneration and the story and history are important to retell as Daniel Drucker reviews for us in ⁦‪@NEJM‬⁩. Congrats to the award winners of the 2024… pic.twitter.com/T2AFiuCJMa 10/20/24, 8:44 AM Joseph Thornton